RELATED CONTENT
NEWS
- Lyrica met goal in study of central neuropathic pain after spinal cord injury
- Upsher-Smith begins Phase III trial of intranasal midazolam for epilepsy seizure clusters
- ARISTOTLE: changing thinking about BMS/Pfizer's Eliquis in anticoagulation?
- SuperGen rises 8.8% on US FDA acceptance of Dacogen sNDA in AML

